Humedix expands aesthetic portfolio with exclusive rights to Reedle Booster in Korea

Humedix, a subsidiary of Huons Group, has secured exclusive distribution rights for EvoV Therapeutics’ “Reedle Booster” series, strengthening its presence in Korea’s competitive aesthetic treatment market.

Reedle Booster PN/EX is a physician-use adaptation of VT Cosmetic’s popular Reedle Shot skincare line.

Co-developed by VT Cosmetics and EvoV Therapeutics, the Reedle Booster is designed for use in dermatology and plastic surgery clinics, offering lower pain and shorter recovery time compared to conventional injectable skin boosters, enabling patients to resume daily activities quickly while achieving immediate skin revitalization.

The product incorporates patented “RED REEDLE” channeling technology, which creates micro-channels on the skin’s surface to deliver active ingredients deep into the dermis.

Two variants will be distributed under the agreement -- Reedle Booster EX, containing next-generation plant-derived exosomes, and Reedle Booster PN, formulated with low-molecular-weight polynucleotides (PN).

Through this partnership, Humedix plans to target the professional aesthetics sector by expanding distribution to dermatology and plastic surgery clinics nationwide.

“By collaborating with Humedix, which has a strong foothold in Korea’s aesthetic market, we aim to showcase the technology behind Reedle Booster and maximize its brand value,” EvoV Therapeutics CEO Park Byung-kook said.

Humedix CEO Kang Min-jong also said, “Reedle Booster is a professional product born from the brand awareness and consumer demand generated by the highly successful Reedle Shot in the K-beauty market.”

It enhances the company’s portfolio with a differentiated epidermis-targeted treatment solution, offering clinics more diverse options, Kang added.